Ovarian Cancer Clinical Trial
Quality of Life in Survivors of Gynecologic Cancer
Summary
RATIONALE: Quality-of-life assessment in cancer survivors may help determine the long-term effects of having had gynecologic cancer and may help improve the quality of life for future cancer survivors.
PURPOSE: This clinical trial is studying the quality of life in survivors of gynecologic cancer.
Full Description
OBJECTIVES:
Describe the significant quality of life (QOL) concerns and long term survivorship issues of women diagnosed and treated for early stage ovarian and endometrial cancer five or more years ago.
Identify mechanisms which contribute to a gynecologic cancer survivorship model through comparison and prediction of high versus low QOL associated with long term adjustment and survivorship. Examine social support, coping efforts, self-efficacy, meaning associated with survivorship, performance status, and age at diagnosis as potential predictors.
Identify and compare factors that predict high versus low QOL for women with early stage endometrial cancer completing participation in GOG-99 clinical trial. Conduct exploratory analysis examining long term QOL concerns of survivors randomized to surgery arm with or without radiotherapy.
OUTLINE: Patients complete one telephone interview with a professional female interviewer. The interview lasts approximately 60 minutes and is audiotaped.
PROJECTED ACCRUAL: A total of 197 early stage endometrial cancer survivors and 114 early stage ovarian cancer survivors will be accrued for this study within 2 years.
Eligibility Criteria
DISEASE CHARACTERISTICS:
Histologically confirmed early stage ovarian and endometrial cancer survivors treated and diagnosed five or more years ago
Patients completing treatment in GOG-95 or GOG-99 protocols at least 5 years ago with no recurrence of disease
Patients with secondary malignancy or under treatment for other medical conditions are eligible
PATIENT CHARACTERISTICS:
Age:
Not specified
Performance status:
Not specified
Life expectancy:
Not specified
Hematopoietic:
Not specified
Hepatic:
Not specified
Renal:
Not specified
Other:
Must be capable of completing telephone interview in English
PRIOR CONCURRENT THERAPY:
Biologic therapy:
See Disease Characteristics
Chemotherapy:
See Disease Characteristics
Endocrine therapy:
See Disease Characteristics
Radiotherapy:
See Disease Characteristics
Surgery:
See Disease Characteristics
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 44 Locations for this study
Birmingham Alabama, 35294, United States
Los Angeles California, 90095, United States
Los Gatos California, 95032, United States
Orange California, 92868, United States
Denver Colorado, 80010, United States
Washington District of Columbia, 20307, United States
Tampa Florida, 33612, United States
Chicago Illinois, 60612, United States
Chicago Illinois, 60637, United States
Indianapolis Indiana, 46202, United States
Iowa City Iowa, 52242, United States
Lexington Kentucky, 40536, United States
Boston Massachusetts, 02111, United States
Worcester Massachusetts, 01655, United States
Jackson Mississippi, 39216, United States
Saint Louis Missouri, 63110, United States
Billings Montana, 59101, United States
Camden New Jersey, 08103, United States
Albany New York, 12208, United States
Brooklyn New York, 11203, United States
Manhasset New York, 11030, United States
New York New York, 10021, United States
Rochester New York, 14642, United States
Stony Brook New York, 11790, United States
Chapel Hill North Carolina, 27599, United States
Durham North Carolina, 27710, United States
Winston-Salem North Carolina, 27157, United States
Cincinnati Ohio, 45267, United States
Cleveland Ohio, 44106, United States
Cleveland Ohio, 44195, United States
Columbus Ohio, 43210, United States
Oklahoma City Oklahoma, 73190, United States
Abington Pennsylvania, 19001, United States
Hershey Pennsylvania, 17033, United States
Philadelphia Pennsylvania, 19104, United States
Philadelphia Pennsylvania, 19107, United States
Philadelphia Pennsylvania, 19111, United States
Charleston South Carolina, 29425, United States
Nashville Tennessee, 37203, United States
Dallas Texas, 75235, United States
Houston Texas, 77030, United States
Seattle Washington, 98109, United States
Tacoma Washington, 98405, United States
Calgary Alberta, T2N 4, Canada
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.